Skip to Main Content

Paper Details

Oligorecurrent nodal prostate cancer: Radiotherapy quality assurance of the randomized PEACE V-STORM phase II trial.
Radiother Oncol
2
2022
Author NameAffiliation
Almudena ZapateroUniversity Hospital La Princesa
Piet OstGhent University Hospital, Ghent University
  • 1 - 2

Datasets

Release 1.2